Apotheka acquires two pharmacy outlets from Panpharmacy
In a strategic move that signifies the ongoing consolidation and growth within the Latvian pharmaceutical retail sector, Panpharmacy, the parent company of the leading online pharmacy InternetAptieka.lv, has successfully completed the sale of two of its brick-and-mortar pharmacies to Apotheka. These pharmacies, both situated in the capital city of Riga, will continue to serve customers under the Apotheka brand, marking a seamless transition in ownership and operations.
InternetAptieka.lv is recognized as the premier online pharmacy platform in Latvia, offering a wide range of pharmaceutical products and health-related services to its customers. This divestiture allows Panpharmacy to potentially refocus resources and further strengthen its leading position in the digital pharmacy space.
Apotheka is a prominent name in the Latvian pharmaceutical retail landscape. The company currently operates more than 120 pharmacies across Latvia, with a significant presence in Riga as well as major cities such as Liepaja, Ventspils, Jelgava, Daugavpils and Rezekne. Apotheka is part of Magnum Group, a leading group in pharmaceutical wholesaling and retailing in the Baltic States.
Oaklins’ team in Latvia acted as the exclusive M&A advisor to Panpharmacy and its shareholders.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more